By: Olivia Dimmer
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the journal Blood.
United States (National)


Not enough data
Olivia's coverage primarily revolves around scientific and healthcare topics, with a strong emphasis on citing data and expert commentary. She seems particularly interested in research findings, especially those related to medical advancements, genetics, neuroscience, and artificial intelligence within the healthcare industry.
Given her focus on citing data and expert commentary, sources who can provide detailed insights into new research findings or offer analysis of scientific developments would likely resonate with Olivia. Those involved in cutting-edge medical or technological research may also capture her attention.
Olivia does not appear to have a specific geographic focus but rather takes an international view of scientific and healthcare innovations. Therefore, experts from various locations contributing to significant global advancements are likely to appeal to her interests.
This information evolves through artificial intelligence and human feedback. Improve this profile .